Related Experiment Videos
Amelioration of bronchopulmonary dysplasia after vitamin E administration. A preliminary report
Insights
Vitamin E supplementation in newborns with respiratory-distress syndrome may prevent bronchopulmonary dysplasia. This study found that vitamin E-treated infants had significantly fewer cases and better survival rates compared to controls.
Area of Science:
- Neonatal Medicine
- Pediatric Pulmonology
- Nutritional Science
Background:
- Bronchopulmonary dysplasia (BPD) is a chronic lung disease affecting premature infants.
- Respiratory-distress syndrome (RDS) is a common condition in neonates requiring respiratory support.
- The long-term effects of RDS and its treatments on neonatal lung development are significant.
Purpose of the Study:
- To investigate the efficacy of vitamin E in preventing bronchopulmonary dysplasia in neonates with respiratory-distress syndrome.
- To assess the impact of vitamin E administration on the incidence of BPD and mortality rates.
- To determine if early vitamin E supplementation influences the severity of lung injury in infants with RDS.
Main Methods:
- A randomized controlled trial involving 40 neonates diagnosed with respiratory-distress syndrome.
- Twenty infants received intramuscular vitamin E during the acute phase of RDS.
- Twenty infants served as a control group, receiving standard care.
Main Results:
- Vitamin E administration significantly increased serum vitamin E concentrations.
- Nine of 20 vitamin E-treated infants (45%) required prolonged oxygen (>250 hours), compared to 13 of 20 controls (65%).
- None of the vitamin E-treated infants developed bronchopulmonary dysplasia, while six controls did (P = 0.046); all vitamin E-treated infants survived, whereas four controls died.
Conclusions:
- Early administration of vitamin E during the acute phase of respiratory-distress syndrome appears to be a protective factor against the development of bronchopulmonary dysplasia.
- Vitamin E supplementation may reduce the severity of lung injury and improve survival rates in neonates with RDS.
- Further research is warranted to confirm these findings and establish optimal dosing and timing for vitamin E therapy in this population.
Abstract:
We studied the effect of vitamin E on the development of bronchopulmonary dysplasis in neonates with respiratory-distress syndrome. Twenty infants received vitamin E administered intramuscularly during the acute phase of the syndrome, and 20 infants served as controls. Administration of vitamin E significantly increased the serum vitamin E concentration. Nine vitamin-treated and 13 control patients required supplemental oxygen for longer than 250 hours; all were treated with positive-pressure ventilation and endotracheal continuous distending airway pressure. Six of those 13 controls had x-ray changes consistent with bronchopulmonary dysplasia, and four died. None of the nine vitamin-treated patients had changes characteristic of bronchopulmonary dysplasia (P = 0.046), and all survived. Administration of vitamin E during the acute phase of the respiratory-distress syndrome appears to modify the development of bronchopulmonary dysplasis.